Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination
- 28 June 2004
- journal article
- Published by Elsevier in International Journal of Medical Microbiology
- Vol. 294 (1) , 35-44
- https://doi.org/10.1016/j.ijmm.2003.12.002
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- A Recombinant Carboxy-Terminal Domain of the Protective Antigen of Bacillus anthracis Protects Mice against Anthrax InfectionInfection and Immunity, 2002
- Modifying the cellular transport of DNA-based vaccines alters the immune response to hantavirus nucleocapsid proteinVaccine, 2001
- Protection against Anthrax Lethal Toxin Challenge by Genetic Immunization with a Plasmid Encoding the Lethal Factor ProteinInfection and Immunity, 2001
- Search for Correlates of Protective Immunity Conferred by Anthrax VaccineInfection and Immunity, 2001
- Lethal factor of Bacillus anthracis cleaves the N-terminus of MAPKKs: analysis of the intracellular consequences in macrophagesInternational Journal of Medical Microbiology, 2000
- Proteolytic Inactivation of MAP-Kinase-Kinase by Anthrax Lethal FactorScience, 1998
- Non-toxigenic derivatives of the Ames strain of Bacillus anthracis are fully virulent for mice: role of plasmid pX02 and chromosome in strain-dependent virulenceMicrobial Pathogenesis, 1993
- Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell killJournal of Immunological Methods, 1989
- Recent advances in the development of an improved, human anthrax vaccineEuropean Journal of Epidemiology, 1988
- Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells.Proceedings of the National Academy of Sciences, 1982